FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

This report summarizes the U.S. Food and Drug Administration (FDA)'s approval of temsirolimus (Torisel®), on May 30, 2007, for the treatment of advanced renal cell carcinoma (RCC). Information provided includes regulatory history, study design, study results, and literature review. A multicente...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Mitchell, Shan Sun, Sridhara, Rajeshwari, Pazdur, Richard
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2010
Aiheet:
Regulatory Issues: FDA
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227966/
https://ncbi.nlm.nih.gov/pubmed/20332142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0178
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia